Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Vitrolife AB

Capitalization 12.68B 1.38B 1.19B 1.07B 1.03B 1.88B 127B 1.96B 5.08B 60.75B 5.17B 5.06B 217B P/E ratio 2025
-3.7x
P/E ratio 2026 * 24x
Enterprise value 13.12B 1.43B 1.23B 1.11B 1.06B 1.94B 131B 2.03B 5.26B 62.84B 5.35B 5.24B 225B EV / Sales 2025
5.62x
EV / Sales 2026 * 3.63x
Free-Float
55.41%
Yield 2025
0.8%
Yield 2026 * 1.2%
1 day+0.16%
1 week-1.83%
Current month-1.83%
1 month+3.14%
3 months-31.64%
6 months-31.59%
Current year-31.64%
1 week 90.7
Extreme 90.7
95.75
1 month 84.9
Extreme 84.9
95.75
Current year 84.9
Extreme 84.9
139.6
1 year 84.9
Extreme 84.9
182.8
3 years 84.9
Extreme 84.9
268
5 years 84.9
Extreme 84.9
585
10 years 59.7
Extreme 59.7
585
Manager TitleAgeSince
Chief Executive Officer 52 31/07/2023
Director of Finance/CFO 55 09/10/2025
Chief Tech/Sci/R&D Officer - 31/12/2021
Director TitleAgeSince
Director/Board Member 63 18/04/2013
Chairman 70 31/07/2023
Director/Board Member 66 26/04/2018
Change 5d. change 1-year change 3-years change Capi.($)
+0.16%-1.83%-44.59%-58.38% 1.38B
+0.16%-4.60%-17.26%+1.04% 13.06B
-1.49%-2.88%+131.94%+215.79% 11.96B
+4.83%+4.11%-9.89%-5.27% 6.21B
-3.28%-7.70% - - 5.25B
-4.91%-3.14%-31.77%-3.56% 4.69B
0.00%-3.15%-28.48%-39.96% 4.31B
-2.45%+10.48%+16.35%+1.47% 2.99B
+1.74%-3.61%-16.55%-42.51% 2.9B
-3.84%-9.72%+77.86%-57.52% 2.66B
Average -0.91%-2.70%+8.62%+1.23% 5.54B
Weighted average by Cap. -0.69%-2.68%+23.25%+40.29%

Financials

2025 2026 *
Net sales 3.45B 375M 323M 292M 280M 511M 34.47B 535M 1.38B 16.53B 1.41B 1.38B 59.12B 3.55B 386M 333M 301M 288M 526M 35.48B 550M 1.42B 17.02B 1.45B 1.42B 60.85B
Net income -1.36B -148M -128M -115M -111M -202M -13.63B -211M -547M -6.53B -556M -545M -23.37B 530M 57.58M 49.64M 44.81M 43M 78.41M 5.29B 82.06M 212M 2.54B 216M 211M 9.08B
Net Debt 437M 47.47M 40.93M 36.95M 35.45M 64.65M 4.36B 67.66M 175M 2.09B 178M 174M 7.48B 201M 21.87M 18.86M 17.03M 16.34M 29.79M 2.01B 31.18M 80.63M 964M 82.1M 80.35M 3.45B
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,151
Date Price Change Volume
06/03/26 93.65 kr +0.16% 248,445
05/03/26 93.50 kr -0.21% 169,918
04/03/26 93.70 kr +1.46% 140,326
03/03/26 92.35 kr -0.59% 160,630
02/03/26 92.90 kr -2.62% 653,239
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
93.65SEK
Average target price
176.75SEK
Spread / Average Target
+88.73%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW